Cargando…
Eptifibatide-induced acute profound thrombocytopenia: A case report
Eptifibatide is an antiplatelet agent used in the medical management of acute coronary syndrome. Although multiple studies did not reveal a significant association between eptifibatide and the development of thrombocytopenia, recent case reports brought attention to this relatively rare side effect....
Autores principales: | Alamin, Mohammed A., Al-Mashdali, Abdulrahman, Al Kindi, Dawoud I., Elshaikh, Elkhansa A., Othman, Fahmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592370/ https://www.ncbi.nlm.nih.gov/pubmed/36281191 http://dx.doi.org/10.1097/MD.0000000000028243 |
Ejemplares similares
-
Eptifibatide-induced acute profound thrombocytopenia: a case report
por: Graidis, Christos, et al.
Publicado: (2014) -
Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia
por: Aljundi, Amer, et al.
Publicado: (2020) -
Profound thrombocytopenia after primary exposure to eptifibatide
por: Norgard, Nicholas B, et al.
Publicado: (2010) -
Acute Profound Thrombocytopenia Induced by Eptifibatide Causing Diffuse Alveolar Hemorrhage
por: Byrd, Gregory, et al.
Publicado: (2021) -
Fatal native aortic valve fungal endocarditis caused by Aspergillus flavus: A case report
por: Al-Mashdali, Abdulrahman F., et al.
Publicado: (2021)